Yeh‐Hsing Lao

3.5k total citations
59 papers, 2.8k citations indexed

About

Yeh‐Hsing Lao is a scholar working on Molecular Biology, Biomedical Engineering and Materials Chemistry. According to data from OpenAlex, Yeh‐Hsing Lao has authored 59 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 21 papers in Biomedical Engineering and 11 papers in Materials Chemistry. Recurrent topics in Yeh‐Hsing Lao's work include CRISPR and Genetic Engineering (16 papers), RNA Interference and Gene Delivery (15 papers) and Advanced biosensing and bioanalysis techniques (15 papers). Yeh‐Hsing Lao is often cited by papers focused on CRISPR and Genetic Engineering (16 papers), RNA Interference and Gene Delivery (15 papers) and Advanced biosensing and bioanalysis techniques (15 papers). Yeh‐Hsing Lao collaborates with scholars based in United States, China and Hong Kong. Yeh‐Hsing Lao's co-authors include Kam W. Leong, Mingqiang Li, Dan Shao, Hanze Hu, Kyle K.L. Phua, Huize Yan, Ji Sun Park, Lin‐Chi Chen, Smruthi Suryaprakash and Yu Tao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Nature Communications.

In The Last Decade

Yeh‐Hsing Lao

59 papers receiving 2.8k citations

Peers

Countries citing papers authored by Yeh‐Hsing Lao

Since Specialization

Citations

This map shows the geographic impact of Yeh‐Hsing Lao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yeh‐Hsing Lao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yeh‐Hsing Lao more than expected).

Fields of papers citing papers by Yeh‐Hsing Lao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yeh‐Hsing Lao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yeh‐Hsing Lao. The network helps show where Yeh‐Hsing Lao may publish in the future.

Co-authorship network of co-authors of Yeh‐Hsing Lao

This figure shows the co-authorship network connecting the top 25 collaborators of Yeh‐Hsing Lao. A scholar is included among the top collaborators of Yeh‐Hsing Lao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yeh‐Hsing Lao. Yeh‐Hsing Lao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mesenchymal stromal/stem cell spheroid-derived extracellular vesicles advance the therapeutic efficacy of 3D-printed vascularized artificial liver lobules in liver failure treatment 2025 ·Bioactive Materials ·Jiabin Zhang, (unknown), Yurong Chai, Yuanyuan Jin, (unknown), Chenya Zhuo, Yanteng Xu, Haixia Wang, Enguo Ju, Yeh‐Hsing Lao, Xi Xie, Mingqiang Li, Yu Tao	3
2	Squidiff: predicting cellular development and responses to perturbations using a diffusion model 2025 ·Nature Methods ·Siyu He, Yuefei Zhu, Daniel Naveed Tavakol, (unknown), Yeh‐Hsing Lao, Zhehao Zhu, Cong Xu, (unknown), Guy Garty, Raju Tomer, Gordana Vunjak‐Novakovic, James Zou, Elham Azizi, Kam W. Leong	3
3	An antifouling membrane-fusogenic liposome for effective intracellular delivery in vivo 2024 ·Nature Communications ·Huimin Kong, (unknown), Ke Yi, Rachel L. Mintz, Yeh‐Hsing Lao, Yu Tao, Mingqiang Li	31
4	Enabling continuous immune cell recirculation on a microfluidic array to study immunotherapeutic interactions in a recapitulated tumour microenvironment 2024 ·Lab on a Chip ·Chun‐Wei Chi, Yeh‐Hsing Lao, (unknown), Siyu He, Taha Merghoub, Kam W. Leong, Sihong Wang	3
5	Spatiotemporal release of non-nucleotide STING agonist and AKT inhibitor from implantable 3D-printed scaffold for amplified cancer immunotherapy 2024 ·Biomaterials ·Haixia Wang, Zheng Liu, (unknown), (unknown), (unknown), Yanteng Xu, Xiangfu Zhou, Qingxi Yuan, Shixian Lv, (unknown), Yeh‐Hsing Lao, Yu Tao, Mingqiang Li	18
6	Optimization of lipid nanoparticles for gene editing of the liver via intraduodenal delivery 2024 ·Biomaterials ·Yining Zhu, Shuting Cai, (unknown), (unknown), Christine Wei, (unknown), (unknown), (unknown), (unknown), Jiayuan Kong, (unknown), Yeh‐Hsing Lao, Kam W. Leong, Hai‐Quan Mao	10
7	Smart Microneedle Arrays Integrating Cell‐Free Therapy and Nanocatalysis to Treat Liver Fibrosis (Adv. Sci. 31/2024) 2024 ·Advanced Science ·Yanteng Xu, Yixin Zhang, Hao Tian, (unknown), Ke Yi, (unknown), Tiantian Xue, Haixia Wang, Yeh‐Hsing Lao, Yingying Xu, Yinxiong Li, Ling Long, (unknown), Yu Tao, Mingqiang Li	1
8	Hepatocyte-confined CRISPR/Cas9-based nanocleaver precisely eliminates viral DNA for efficient and safe treatment of hepatitis B virus infection 2023 ·Nano Today ·Huimin Kong, Chenya Zhuo, Ke Yi, Chunxiong Zheng, Rachel L. Mintz, Yeh‐Hsing Lao, (unknown), Enguo Ju, Haixia Wang, Dan Shao, Haihua Xiao, Yu Tao, Mingqiang Li	16
9	Stem cell-derived hepatocyte therapy using versatile biomimetic nanozyme incorporated nanofiber-reinforced decellularized extracellular matrix hydrogels for the treatment of acute liver failure 2023 ·Bioactive Materials ·Yuanyuan Jin, Jiabin Zhang, Yanteng Xu, Ke Yi, (unknown), (unknown), Haixia Wang, Hon Fai Chan, Yeh‐Hsing Lao, Shixian Lv, Yu Tao, Mingqiang Li	44
10	Magnetic‐Activated Nanosystem with Liver‐Specific CRISPR Nonviral Vector to Achieve Spatiotemporal Liver Genome Editing as Hepatitis B Therapeutics (Adv. Funct. Mater. 7/2023) 2023 ·Advanced Functional Materials ·Chenya Zhuo, (unknown), Ke Yi, Chun‐Wei Chi, Jiabin Zhang, Ran Chen, Haixia Wang, (unknown), Yeh‐Hsing Lao, Yu Tao, Mingqiang Li	1
11	Targeting Proinflammatory Molecules Using Multifunctional MnO Nanoparticles to Inhibit Breast Cancer Recurrence and Metastasis 2022 ·ACS Nano ·Yiling Zhong, Tianyu Li, Yuefei Zhu, Jie Zhou, (unknown), Joung-Hyun Lee, Feng Liu, (unknown), Yeh‐Hsing Lao, Chai Hoon Quek, Dan Shao, Kam W. Leong	32
12	Nanoparticulate cell-free DNA scavenger for treating inflammatory bone loss in periodontitis 2022 ·Nature Communications ·Hanyao Huang, Weiyi Pan, Yifan Wang, Hye Sung Kim, Dan Shao, (unknown), Tzu‐Chieh Ho, Yeh‐Hsing Lao, Chai Hoon Quek, (unknown), Qianming Chen, (unknown), Shengmin Zhang, Леи Жао, Kam W. Leong	90
13	Self-intensified synergy of a versatile biomimetic nanozyme and doxorubicin on electrospun fibers to inhibit postsurgical tumor recurrence and metastasis 2022 ·Biomaterials ·Yongwei Hu, Yanteng Xu, Rachel L. Mintz, (unknown), (unknown), Yeh‐Hsing Lao, Hon Fai Chan, Kai Li, Shixian Lv, Guojun Chen, Yu Tao, Yun Luo, Mingqiang Li	40
14	Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma (Adv. Sci. 24/2021) 2021 ·Advanced Science ·Huimin Kong, Enguo Ju, Ke Yi, Weiguo Xu, Yeh‐Hsing Lao, Du Cheng, Qi Zhang, Yu Tao, Mingqiang Li, Jianxun Ding	2
15	Treatment of severe sepsis with nanoparticulate cell-free DNA scavengers 2020 ·Science Advances ·Jianati Dawulieti, Madi Sun, Yawei Zhao, Dan Shao, Huize Yan, Yeh‐Hsing Lao, Hanze Hu, Lianzhi Cui, Xiaoyan Lv, Feng Liu, Chun‐Wei Chi, Yue Zhang, Mingqiang Li, Ming Zhang, Huayu Tian, Xuesi Chen, Kam W. Leong, Li Chen	143
16	A Versatile Nonviral Delivery System for Multiplex Gene‐Editing in the Liver 2020 ·Advanced Materials ·Jing Gong, Hongxia Wang, Yeh‐Hsing Lao, Hanze Hu, (unknown), Jonathan Guo, Tzu‐Chieh Ho, Dantong Huang, Mingqiang Li, Dan Shao, Kam W. Leong	68
17	High‐Throughput Tumor‐on‐a‐Chip Platform to Study Tumor–Stroma Interactions and Drug Pharmacokinetics 2020 ·Advanced Healthcare Materials ·Chun‐Wei Chi, Yeh‐Hsing Lao, (unknown), (unknown), (unknown), (unknown), Bingmei M. Fu, Kam W. Leong, Sihong Wang	41
18	Engineering Cell Membrane‐Based Nanotherapeutics to Target Inflammation 2019 ·Advanced Science ·Huize Yan, Dan Shao, Yeh‐Hsing Lao, Mingqiang Li, Hanze Hu, Kam W. Leong	207
19	Bioinspired Diselenide‐Bridged Mesoporous Silica Nanoparticles for Dual‐Responsive Protein Delivery 2018 ·Advanced Materials ·Dan Shao, Mingqiang Li, Zheng Wang, Xiao Zheng, Yeh‐Hsing Lao, Zhimin Chang, Fan Zhang, Mengmeng Lu, Juan Yue, Hanze Hu, Huize Yan, Li Chen, (unknown), Kam W. Leong	325
20	Engineering mesenchymal stem cells for regenerative medicine and drug delivery 2015 ·Methods ·Ji Sun Park, Smruthi Suryaprakash, Yeh‐Hsing Lao, Kam W. Leong	183

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact